CHCs are the most used methods of contraception in the more developed world. Their use does not increase the risk of breast cancer in women with a family history of BC from our Family Cancer Clinic. These results are confirmed for very-high-risk (BRCA1-2), high-risk and intermediate-risk groups. Background: We estimated the association between...
-
2018 (v1)PublicationUploaded on: April 14, 2023
-
2017 (v1)Publication
Reproductive history and exogenous hormonal exposures are acknowledged risk factors for breast cancer in the general population. In women at increased breast cancer risk for genetic predisposition or positive family history, data regarding these risk factors are limited or con icting, and recommendations for these categories are unclear. We...
Uploaded on: April 14, 2023 -
2016 (v1)Publication
Background and objectives: Relevant heterogeneity exists among Postgraduate Schools in Medical Oncology, also within the same country. In order to provide a comprehensive overview of the landscape of Italian Postgraduate Schools in Medical Oncology, the Italian Association of Medical Oncology (AIOM) undertook an online survey, inviting all the...
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2023 (v1)Publication
Adjuvant chemotherapy recommendations for ER+/HER2- early-stage breast cancers (eBC) involve integrating prognostic and predictive information which rely on physician judgment; this can lead to discordant recommendations. In this study we aim to evaluate whether Oncotype DX improves confidence and agreement among oncologists in adjuvant...
Uploaded on: February 14, 2024 -
2024 (v1)Publication
Background and aim: Germline BRCA1-2 test is routinely recommended in Pancreatic Cancer (PC) patients, due to its clinical-epidemiological relevance. Data on the prevalence of germline pathogenic variants (gPV) in other cancer predisposition and DNA Damage Repair (DDR) system-related genes in unselected PC cases are sparce in Italy. We assessed...
Uploaded on: August 7, 2024